{"id":169109,"date":"2020-05-26T19:00:40","date_gmt":"2020-05-26T19:00:40","guid":{"rendered":"https:\/\/stockchase.com\/discover\/?p=169109"},"modified":"2020-05-27T14:56:52","modified_gmt":"2020-05-27T14:56:52","slug":"top-stocks-covid-19-vaccine-race","status":"publish","type":"post","link":"https:\/\/stockchase.com\/discover\/top-stocks-covid-19-vaccine-race\/","title":{"rendered":"Top Covid-19 Vaccine Stocks to Bet on the Immunization Race (Updated)"},"content":{"rendered":"

Last week, we explored 4 Covid-19 Vaccine Stocks actively testing Covid-19 vaccines : Moderna<\/a>, Pfizer<\/a>, Inovio and AstraZeneca<\/a>.<\/p>\n

This week, we look at four more, including one partnership.<\/p>\n

In many cases, public companies are partnering with universities and governments to test their vaccines. Needless to say, the stakes are huge: a vaccine would allow economies to return to normal, and for the winning company itself Morgan Stanley<\/a> estimates revenues of US$10-30 billion during this pandemic plus anywhere from $2-25 billion <\/span>annually <\/i><\/span>thereafter. <\/span><\/p>\n

Investors and world governments alike have been throwing money into research, as witnessed by CNBC’s Covid-19 Testing and Treatments Index<\/a>, which includes Covid-19 Vaccine stocks, is currently riding new highs. (Update: Merck<\/a> has just entered the vaccine sweepstakes.)
\n<\/span><\/p>\n

I<\/span>t takes 12-18 months to bring a vaccine to market, and America’s top <\/span>infectious disease expert<\/span><\/a><\/u><\/span><\/span> is confident that one will emerge. <\/span><\/p>\n

With last January as the starting point when Inovio began testing, then January 2021 through summer 2021 is the expected delivery date. Also, there are another 100 or so vaccine candidates that are awaiting approval to test.<\/span><\/p>\n

\"Sanofi<\/p>\n

\n
\n

Discover What's Inside<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n